Will Kezar's stock price reach $2.00/share by June 2025? | Binary | | | 2 months ago | |
Will Kezar accept Concentra's $1.10/share proposal by end of 2024? | Binary | | | 2 months ago | |
Will Tang Capital increase stake in Kezar to over 15% by March 2025? | Binary | | | 2 months ago | |
What will be the outcome of Concentra's acquisition proposal for Kezar by end of 2024? | Categorical | | | 2 months ago | |
What will be Kezar's stock price range by end of Q1 2025? | Categorical | | | 2 months ago | |
Will Kezar Life Sciences receive a clinical hold letter from the FDA by the end of 2024? | Binary | | | 3 months ago | |
Will Kezar Life Sciences resume enrollment in the Zetomipzomib Lupus Nephritis trial by March 31, 2025? | Binary | | | 3 months ago | |
How will Kezar Life Sciences' stock price change by December 31, 2024? | Categorical | | | 3 months ago | |
What major strategic move will Kezar make by June 2025? | Categorical | | | 2 months ago | |
What regulatory action will EMA take on Kezar Life Sciences' Zetomipzomib Lupus Nephritis trial by March 31, 2025? | Categorical | | | 3 months ago | |
What will be the outcome of the FDA review of Kezar Life Sciences' Zetomipzomib Lupus Nephritis trial by March 31, 2025? | Categorical | | | 3 months ago | |
Will Kezar Life Sciences announce new safety measures for the Zetomipzomib Lupus Nephritis trial by December 31, 2024? | Binary | | | 3 months ago | |
